Participants 451 583 6
Patients (N = 207) with nonresectable rectal cancer were randomized to preoperative CRT or RT (2 Gy × 25 ± 5-fluorouracil/leucovor
Participants 980 1079 4
S Of the 105 patients alive in Norway and Sweden after 4 to 12 years of follow-up, 78 (74%) respond
